CORVEL CORP (CRVL)
US2210061097 - Common Stock
CRVL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 113 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CRVL a very profitable company, without any liquidiy or solvency issues. CRVL does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CRVL was profitable.
In the past year CRVL had a positive cash flow from operations.
In the past 5 years CRVL has always been profitable.
In the past 5 years CRVL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 15.72%, CRVL belongs to the top of the industry, outperforming 97.35% of the companies in the same industry.
The Return On Equity of CRVL (28.83%) is better than 95.58% of its industry peers.
Looking at the Return On Invested Capital, with a value of 26.38%, CRVL belongs to the top of the industry, outperforming 99.11% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRVL is significantly above the industry average of 8.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.72% | ||
| ROE | 28.83% | ||
| ROIC | 26.38% |
ROA(3y)16.54%
ROA(5y)14.39%
ROE(3y)31.63%
ROE(5y)28.19%
ROIC(3y)28.37%
ROIC(5y)24.01%
1.3 Margins
CRVL has a Profit Margin of 9.64%. This is amongst the best in the industry. CRVL outperforms 95.58% of its industry peers.
CRVL's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 12.02%, CRVL belongs to the best of the industry, outperforming 87.61% of the companies in the same industry.
In the last couple of years the Operating Margin of CRVL has grown nicely.
The Gross Margin of CRVL (21.81%) is comparable to the rest of the industry.
CRVL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.02% | ||
| PM (TTM) | 9.64% | ||
| GM | 21.81% |
OM growth 3Y3.73%
OM growth 5Y2.98%
PM growth 3Y4.52%
PM growth 5Y4.11%
GM growth 3Y-1.17%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
CRVL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CRVL has been reduced compared to 1 year ago.
Compared to 5 years ago, CRVL has less shares outstanding
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CRVL has an Altman-Z score of 20.63. This indicates that CRVL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 20.63, CRVL belongs to the top of the industry, outperforming 97.35% of the companies in the same industry.
There is no outstanding debt for CRVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 20.63 |
ROIC/WACC2.92
WACC9.05%
2.3 Liquidity
A Current Ratio of 1.71 indicates that CRVL should not have too much problems paying its short term obligations.
CRVL has a Current ratio of 1.71. This is in the better half of the industry: CRVL outperforms 61.95% of its industry peers.
CRVL has a Quick Ratio of 1.71. This is a normal value and indicates that CRVL is financially healthy and should not expect problems in meeting its short term obligations.
CRVL has a better Quick ratio (1.71) than 66.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.67% over the past year.
The Earnings Per Share has been growing by 12.40% on average over the past years. This is quite good.
CRVL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.66%.
The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)9.67%
EPS 3Y19.9%
EPS 5Y12.4%
EPS Q2Q%17.33%
Revenue 1Y (TTM)12.66%
Revenue growth 3Y12.9%
Revenue growth 5Y5.95%
Sales Q2Q%14.77%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 78.54 indicates a quite expensive valuation of CRVL.
The rest of the industry has a similar Price/Earnings ratio as CRVL.
The average S&P500 Price/Earnings ratio is at 28.96. CRVL is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.54 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CRVL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, CRVL is valued a bit cheaper than 61.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.8 | ||
| EV/EBITDA | 46.57 |
4.3 Compensation for Growth
CRVL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)6.33
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CRVL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CORVEL CORP
NASDAQ:CRVL (11/22/2024, 3:17:01 PM)
369.12
+8.93 (+2.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.32B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 78.54 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)6.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.72% | ||
| ROE | 28.83% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 12.02% | ||
| PM (TTM) | 9.64% | ||
| GM | 21.81% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.71 | ||
| Quick Ratio | 1.71 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)9.67%
EPS 3Y19.9%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.66%
Revenue growth 3Y12.9%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y